The effect of respiratory syncytial virus (RSV) or mixtures of RSV and its specific antibody on the oxidative metabolic activity ofhuman polymorphonuclear leukocytes was studied by the technique of luminol-dependent chemiluminescence. Peripheral blood neutrophils obtained from normal healthy donors were used. RSV alone failed to induce any chemiluminescent response by the neutrophils. However, mixtures of RSV and RSV antibody-positive serum regularly elicited significant neutrophil chemiluminescence. Ultracentrifugation, electron microscopy, and Raji cell immune complex assays of virus-antibody mixtures suggested that the neutrophil chemiluminescent response was related to the presence of specific immune complexes of RSV antigen-antibody. Heat inactivation of the serum significantly reduced the polymorphonuclear leukocyte chemiluminescence, and the response also appeared to be dependent on the dose of the virus and the antibody in the reaction mixture. It is proposed that interaction between the neutrophil and RSV-specific immune complexes may contribute to the pathogenesis of RSV infection via the possible release of metabolic products from the activated neutrophils.
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Human infections with respiratory syncytial virus (RSV) are frequently associated with the development of bronchospasm and bronchiolitis, particularly in young infants. Previous studies have demonstrated significant alterations in virus-specific lymphocyte function with severe RSV-induced disease (34) . However, the precise mechanism of RSV-induced bronchospasm remains to be determined. Although the bulk of available evidence suggests that neutrophils play a major role in bacterial diseases, recent studies have indicated that neutrophils may also participate in the early stages of viral infections. For example, neutrophils migrate to the site of viral replication in vivo (3, 11, 29) . In vitro studies have demonstrated the release of leukocyte chemotactants during viral replication in tissue culture (32) . Neutrophils from humans and a variety of animal species have also been shown to inhibit replication of several different viruses in tissue culture settings (9, 26) . Recently, neutrophils have been shown to be associated with the synthesis of mediators that render cells resistant to viral infection (25) . Several studies have also demonstrated that neutrophils in the presence of either antibody or complement are cytotoxic for virus-infected cells (17, 33) . It has been shown that neutrophils can generate thromboxane-A2 upon phagocytic stimulation.
This substance has a potent bronchoconstructive effect (13, 30) . The present studies were undertaken to determine whether the concepts of virus-neutrophil interaction summarized above can be applied to the understanding of the pathogenesis of RSV infection in humans. Series of experiments were carried out to examine the effects of RSV on neutrophil function in vitro and to characterize the role of RSVspecific antibody on neutrophil-RSV interaction.
MATERLALS AND METHODS
Collection and preparation of neutrophils. Heparinized specimens of blood were collected from eight healthy donors. The donors ranged in age from 20 to 35 years and represented both sexes. None of the donors was suffering from any overt clinical illness or receiving any drugs at the time of and for 2 to 3 weeks before the specimen collection. The same donors were bled repeatedly, and all data presented are based on this uniform donor population. All donors were seropositive for antibody to RSV for several months before specimens were collected. Neutrophils were separated by the previously described procedures (4). Briefly, 10 ml of heparinized blood containing 10 (10) . Briefly, 3 ml of HBSS with luminol and 1 ml of PMN were mixed in a plastic scintillation vial (Fischer Scientific Co., Rochester, N.Y.) which had been dark adapted for 24 h. The specimens were counted for 0.2 min at 10-min intervals until the background counts stabilized. The PMN chemiluminescence was determined in consecutive sets of neutrophils from the same donor after treatment with 0.4 ml each of (i) RSV and HBSS alone, (ii) RSV pretreated with RSV antibody-positive serum, (iii) uninfected HEp-2 cell control with RSV antibody-positive serum, (iv) RSV antibody-positive serum alone, and (v) HBSS alone. The antibody-positive serum specimens used for these studies had an RSV antibody titer of 1:32. All preparations were preincubated at room temperature for 30 min before addition of neutrophils for scintillation counts.
Detection of immune complexes. All preparations listed above which were tested for chemiluminescence were also examined for the presence of immune complexes by the Raji cell radioimmunoassay as described previously (31) .
Electron microscope examination. Several preparations of RSV alone, virus-antibody, and cell control were treated with 1% ammonium acetate, negatively stained with 2% phosphotungstic acid, and examined under an electron microscope for the presence of RSV-specific immune aggregates.
Statistical analysis. Student's t-test was used to
analyze the data.
RESULTS
Effect of RSV on zymosan-and TPA-induced chemiluminescence. Initially, experiments were performed to determine the effects of RSV on zymosan-and TPA-induced chemiluminescence of PMN. Significant zymosan-induced PMN chemiluminescence was observed with live RSV as well as with uninfected tissue culture controls (Fig. 1) (Fig. 2) . The degree of chemiluminescence observed with unheated serum was threefold higher than that with heated serum. Figure 3 (Fig. 4) indicate that the chemiluminescence-inducing activity is largely associ- 14, 18) . One recent report has suggested increased chemiluminescence response and heightened oxidative metabolisn in human phagocytic cells after their interaction with killed mumps virus antigen and specific antibody (5) .
Bronchiolitis due to RSV is a disease primarily of children less than 6 months old, with a peak incidence at 2 months (24) . Severe bronchiolitis has also been observed in children who received an experimental killed vaccine (6, 12) . It has been postulated that natural infection with RSV in these infants resulted in more severe disease, perhaps due to immune complex injury (6 (20, 23, 28) . In mice, immune complex-mediated disease has been observed in infections with lymphocytic choriomeningitis and cytomegalovirus (21, 22 (7) . The interaction between neutrophils and immune complexes has been shown to trigger the release of enzyme granules and a burst of oxidative metabolism (5, 18) . Thus, it is conceivable that the release of these and other potentially toxic substances contributes, in part, to the pathogenesis of viral immune complexinduced tissue damage. Many young patients with RSV infections possess high levels ofmaternal antibody directed against RSV. It has been suggested that bronchiolitis in these patients may be due to the development of immune complexes in the presence of maternally derived specific immunoglobulin G antibody after natural exposure of RSV (2, 6). However, the few histological studies currently available have failed to reveal the presence of immune complexes in the bronchopulmonary tissues of patients with fatal RSV infections (6, 16) . It is possible that the target cells for immune complex interactions in RSV infection may be PMN rather than bronchopulmonary epithelial cells.
Earlier studies have shown that the metabolic activity of PMN as evidenced by Nitro Blue Tetrazolium dye reduction is significantly increased in children with RSV-associated acute bronchiolitis (27) . In the present study, RSV in the absence of antibody did not induce increased metabolic activity in the neutrophils, although significant enhancement of chemiluminescence was observed with virus-antibody complexes. Based on these findings and the observations summarized above, it is suggested that the interaction of neutrophils with RSV-specific immune complexes during the acute phase of RSV infection may contribute to the pathogenesis and severity of clinical disease. These effects may be mediated through the release of thromboxane-A2 and other pharmacological products from metabolically activated neutrophils.
